Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 12 citing articles:

Advancements and challenges in triple-negative breast cancer: a comprehensive review of therapeutic and diagnostic strategies
Nating Xiong, Heming Wu, Zhikang Yu
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 21
Neoadjuvant Strategies for Triple Negative Breast Cancer: Current Evidence and Future Perspectives
Zhenjun Huang, Qing Peng, Luhui Mao, et al.
MedComm – Future Medicine (2025) Vol. 4, Iss. 1
Open Access
Identification of co-regulated genes associated with doxorubicin resistance in the MCF-7/ADR cancer cell line
Ali Miri, Javad Gharechahi, Iman Samiei Mosleh, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 7
Breast Cancer Stem Cells and Tumor Heterogeneity: Characteristics and Therapeutic Strategies
Aleksandra Romaniuk, Ewa Totoń, Magdalena Taube, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2481-2481
Open Access | Times Cited: 2
Based on network pharmacology and molecular docking to explore the protective effect of Epimedii Folium extract on cisplatin-induced intestinal injury in mice
Juan Xia, Jun‐nan Hu, Zi Wang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 10
Drug Shortages in Oncology: ASCO Clinical Guidance for Alternative Treatments
Edgardo S. Santos, Thomas K. Oliver, Christina Lacchetti, et al.
JCO Oncology Practice (2023) Vol. 20, Iss. 1, pp. 19-32
Open Access | Times Cited: 5
The Response of Triple-Negative Breast Cancer to Neoadjuvant Chemotherapy and the Epithelial–Mesenchymal Transition
Stefano Zapperi, Caterina A. M. La Porta
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6422-6422
Open Access | Times Cited: 2
Arylamine N-acetyltransferase 1 deficiency inhibits drug-induced cell death in breast cancer cells: switch from cytochrome C-dependent apoptosis to necroptosis
Courtney E. McAleese, Neville J. Butcher, Rodney F. Minchin
Breast Cancer Research and Treatment (2022) Vol. 195, Iss. 3, pp. 223-236
Open Access | Times Cited: 4
Mind over chronic pain: A meta-analysis of cognitive restructuring in chronically ill adults
Sebastian Pintea, Paula Maier
Journal of Psychosomatic Research (2024) Vol. 184, pp. 111837-111837
Open Access
Arylamine N-acetyltransferase 1 deficiency inhibits drug-induced cell death in breast cancer cells: switch from cytochrome C-dependent apoptosis to necroptosis.
Courtney E. McAleese, Neville J. Butcher, Rodney F. Minchin
Research Square (Research Square) (2022)
Open Access | Times Cited: 1
Authors' reply to Agarwal et al. and Iyer
Ajeet Kumar Gandhi, Ajay Gogia
Cancer Research Statistics and Treatment (2022) Vol. 5, Iss. 1, pp. 152-153
Open Access
Post(neo)adjuvante Therapiekonzepte – Möglichkeiten der Therapieoptimierung
Natalia Krawczyk, Tanja Fehm, Elmar Stickeler, et al.
Der Gynäkologe (2022) Vol. 55, Iss. 5, pp. 324-333
Closed Access
Page 1

Scroll to top